_id
691727be3c536f8df2316c2d
Ticker
VBIZF
Name
Viva Biotech Holdings
Exchange
PINK
Address
No.735, Ziping Road, Shanghai, China, 201318
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.vivabiotech.com.cn
Description
Viva Biotech Holdings, an investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide. The company provides discovery biology services, including protein expression and purification, structural biology, hit discovery, bioassay, biomolecular interaction, and pharmacology and DMPK; chemistry services, such as medicinal and synthetic chemistry, analytical chemistry, purification preparation, and computer-aided drug design services, as well as offers chemical technology platforms; and antibody/biologics research and development services comprising recombinant protein expression platform, antibody discovery and affinity maturation, assay platform, antibody production and identification platform, and antigen-antibody structural resolution platform solutions. It also offers PROTAC/molecular glue services, including protein preparation and ternary complex structure determination, screening for molecule glues and novel E3 ligase ligands, PROTAC ternary complex kinetics, PROTAC degradation assays and ternary complex assays, PROTAC molecule design and synthesis, ADME & PK/PD studies of PROTAC molecules, and computer aided PROTAC design solutions; and XDC platforms, such as XDC conjugation and quality study, XDC chemistry research and development, and XDC functional studies. In addition, the company offers contract development and manufacturing services comprising integrated services for small molecule active pharmaceutical ingredients, formulation development and production services, and pharmaceutical analysis services, as well as CMC filing, global filing registration support, and other services. Further, it provides research services. The company was incorporated in 2008 and is headquartered in Shanghai, China.
Last Close
0.1908
Volume
-
Current Price
0.1908
Change
-21.529745042492916
Last Updated
2026-01-07T14:03:46.336Z
Image
-
Ipo Date
-
Market Cap
622346816
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9964999999999999
Sentiment Sources
2
Current Quarter
2025-06-30
Revenue
831874000
Cost Of Revenue
492447000
Gross Profit
339427000
Operating Expenses
223626000
Operating Income
115801000
Interest Expense
9085000
Pretax Income
171695000
Net Income
121805000
Eps
0.04854682364157175
Dividends Per Share
-
Shares Outstanding
2109650305
Income Tax Expense
23058000
EBITDA
214639000
Operating Margin
13.92049757535396
Total Other Income Expense Net
55894000
Cash
904452000
Short Term Investments
-
Receivables
305745000
Inventories
317074000
Total Current Assets
1746097000
Property Plant Equipment
1572443000
Total Assets
6882873000
Payables
181256000
Short Term Debt
603639000
Long Term Debt
528058000
Total Liabilities
2975397000
Equity
3892794000
Bs_currency_symbol
CNY
Depreciation
107766000
Change In Working Capital
66391000
Cash From Operations
129823000
Capital Expenditures
74826000
Cash From Investing
-14149000
Cash From Financing
-151989000
Net Change In Cash
-
Cf_currency_symbol
-
PE
29.5
PB
0.12297624965513201
ROE
3.1289865325521977
ROA
1.7696825148451816
FCF
54997000
Fcf Percent
0.06611217564198424
Piotroski FScore
4
Health Score
55
Deep Value Investing Score
8
Defensive Investing Score
6.5
Dividend Investing Score
3
Economic Moat Investing Score
8.3
Garp Investing Score
8
Growth Investing Score
7
Momentum Investing Score
5
Net Net Investing Score
4
Quality Investing Score
7
Value Investing Score
6
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
831874000
Quarters > 0 > income Statement > cost Of Revenue
492447000
Quarters > 0 > income Statement > gross Profit
339427000
Quarters > 0 > income Statement > operating Expenses
223626000
Quarters > 0 > income Statement > operating Income
115801000
Quarters > 0 > income Statement > interest Expense
9085000
Quarters > 0 > income Statement > pretax Income
171695000
Quarters > 0 > income Statement > net Income
121805000
Quarters > 0 > income Statement > eps
0.04854682364157175
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
2509021000
Quarters > 0 > income Statement > income Tax Expense
23058000
Quarters > 0 > income Statement > EBITDA
214639000
Quarters > 0 > income Statement > operating Margin
13.92049757535396
Quarters > 0 > income Statement > total Other Income Expense Net
55894000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
904452000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
305745000
Quarters > 0 > balance Sheet > inventories
317074000
Quarters > 0 > balance Sheet > total Current Assets
1746097000
Quarters > 0 > balance Sheet > property Plant Equipment
1572443000
Quarters > 0 > balance Sheet > total Assets
6882873000
Quarters > 0 > balance Sheet > payables
181256000
Quarters > 0 > balance Sheet > short Term Debt
603639000
Quarters > 0 > balance Sheet > long Term Debt
528058000
Quarters > 0 > balance Sheet > total Liabilities
2975397000
Quarters > 0 > balance Sheet > equity
3892794000
Quarters > 0 > balance Sheet > currency_symbol
CNY
Quarters > 0 > cash Flow > net Income
121805000
Quarters > 0 > cash Flow > depreciation
107766000
Quarters > 0 > cash Flow > change In Working Capital
66391000
Quarters > 0 > cash Flow > cash From Operations
129823000
Quarters > 0 > cash Flow > capital Expenditures
74826000
Quarters > 0 > cash Flow > cash From Investing
-14149000
Quarters > 0 > cash Flow > cash From Financing
-151989000
Quarters > 0 > cash Flow > net Change In Cash
-
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
0.04854682364157175
Quarters > 0 > ratios > PB
0.12297624965513201
Quarters > 0 > ratios > ROE
3.1289865325521977
Quarters > 0 > ratios > ROA
1.7696825148451816
Quarters > 0 > ratios > FCF
54997000
Quarters > 0 > ratios > Piotroski FScore
4
Quarters > 0 > ratios > fcf Percent
0.06611217564198424
Quarters > 0 > health Score
55
Quarters > 1 > quarter
2025-03-31
Quarters > 1 > income Statement > revenue
415937000
Quarters > 1 > income Statement > cost Of Revenue
246223500
Quarters > 1 > income Statement > gross Profit
169713500
Quarters > 1 > income Statement > operating Expenses
111813000
Quarters > 1 > income Statement > operating Income
57900500
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
85847500
Quarters > 1 > income Statement > net Income
60902500
Quarters > 1 > income Statement > eps
0.024273411820785875
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
2509021000
Quarters > 1 > income Statement > income Tax Expense
11529000
Quarters > 1 > income Statement > EBITDA
107319500
Quarters > 1 > income Statement > operating Margin
13.92049757535396
Quarters > 1 > income Statement > total Other Income Expense Net
27947000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
904452000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
305745000
Quarters > 1 > balance Sheet > inventories
317074000
Quarters > 1 > balance Sheet > total Current Assets
1746097000
Quarters > 1 > balance Sheet > property Plant Equipment
1572443000
Quarters > 1 > balance Sheet > total Assets
6882873000
Quarters > 1 > balance Sheet > payables
181256000
Quarters > 1 > balance Sheet > short Term Debt
603639000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
2975397000
Quarters > 1 > balance Sheet > equity
3892794000
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
60902500
Quarters > 1 > cash Flow > depreciation
53883000
Quarters > 1 > cash Flow > change In Working Capital
33195500
Quarters > 1 > cash Flow > cash From Operations
64911500
Quarters > 1 > cash Flow > capital Expenditures
37413000
Quarters > 1 > cash Flow > cash From Investing
-7074500
Quarters > 1 > cash Flow > cash From Financing
-75994500
Quarters > 1 > cash Flow > net Change In Cash
-
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
0.024273411820785875
Quarters > 1 > ratios > PB
0.12297624965513201
Quarters > 1 > ratios > ROE
1.5644932662760989
Quarters > 1 > ratios > ROA
0.8848412574225908
Quarters > 1 > ratios > FCF
27498500
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
0.06611217564198424
Quarters > 1 > health Score
53
Quarters > 2 > quarter
2024-12-31
Quarters > 2 > income Statement > revenue
1004827000
Quarters > 2 > income Statement > cost Of Revenue
656573000
Quarters > 2 > income Statement > gross Profit
348254000
Quarters > 2 > income Statement > operating Expenses
240137000
Quarters > 2 > income Statement > operating Income
108117000
Quarters > 2 > income Statement > interest Expense
11051000
Quarters > 2 > income Statement > pretax Income
110189000
Quarters > 2 > income Statement > net Income
50486000
Quarters > 2 > income Statement > eps
0.014043542045785186
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
3594962000
Quarters > 2 > income Statement > income Tax Expense
32439000
Quarters > 2 > income Statement > EBITDA
217317000
Quarters > 2 > income Statement > operating Margin
10.759762625805239
Quarters > 2 > income Statement > total Other Income Expense Net
2072000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
941581000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
436986000
Quarters > 2 > balance Sheet > inventories
272700000
Quarters > 2 > balance Sheet > total Current Assets
1876598000
Quarters > 2 > balance Sheet > property Plant Equipment
1606609000
Quarters > 2 > balance Sheet > total Assets
7050594000
Quarters > 2 > balance Sheet > payables
309355000
Quarters > 2 > balance Sheet > short Term Debt
552484000
Quarters > 2 > balance Sheet > long Term Debt
705921000
Quarters > 2 > balance Sheet > total Liabilities
3234373000
Quarters > 2 > balance Sheet > equity
3802377000
Quarters > 2 > balance Sheet > currency_symbol
CNY
Quarters > 2 > cash Flow > net Income
50486000
Quarters > 2 > cash Flow > depreciation
109884000
Quarters > 2 > cash Flow > change In Working Capital
-65919000
Quarters > 2 > cash Flow > cash From Operations
221660000
Quarters > 2 > cash Flow > capital Expenditures
62322000
Quarters > 2 > cash Flow > cash From Investing
-15691000
Quarters > 2 > cash Flow > cash From Financing
-303152000
Quarters > 2 > cash Flow > net Change In Cash
-
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
0.014043542045785186
Quarters > 2 > ratios > PB
0.18039209410324122
Quarters > 2 > ratios > ROE
1.3277484057998457
Quarters > 2 > ratios > ROA
0.7160531438911388
Quarters > 2 > ratios > FCF
159338000
Quarters > 2 > ratios > Piotroski FScore
4
Quarters > 2 > ratios > fcf Percent
0.15857257020362708
Quarters > 2 > health Score
62
Quarters > 3 > quarter
2024-09-30
Quarters > 3 > income Statement > revenue
502413500
Quarters > 3 > income Statement > cost Of Revenue
328286500
Quarters > 3 > income Statement > gross Profit
174127000
Quarters > 3 > income Statement > operating Expenses
120068500
Quarters > 3 > income Statement > operating Income
54058500
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
55094500
Quarters > 3 > income Statement > net Income
25243000
Quarters > 3 > income Statement > eps
0.007021771022892593
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
3594962000
Quarters > 3 > income Statement > income Tax Expense
16219500
Quarters > 3 > income Statement > EBITDA
108658500
Quarters > 3 > income Statement > operating Margin
10.759762625805239
Quarters > 3 > income Statement > total Other Income Expense Net
1036000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
941581000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
420464000
Quarters > 3 > balance Sheet > inventories
272700000
Quarters > 3 > balance Sheet > total Current Assets
1876598000
Quarters > 3 > balance Sheet > property Plant Equipment
1597318000
Quarters > 3 > balance Sheet > total Assets
7050594000
Quarters > 3 > balance Sheet > payables
309355000
Quarters > 3 > balance Sheet > short Term Debt
552484000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
3234373000
Quarters > 3 > balance Sheet > equity
3802377000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
25243000
Quarters > 3 > cash Flow > depreciation
54942000
Quarters > 3 > cash Flow > change In Working Capital
-32959500
Quarters > 3 > cash Flow > cash From Operations
110830000
Quarters > 3 > cash Flow > capital Expenditures
31161000
Quarters > 3 > cash Flow > cash From Investing
-7845500
Quarters > 3 > cash Flow > cash From Financing
-151576000
Quarters > 3 > cash Flow > net Change In Cash
-
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
0.007021771022892593
Quarters > 3 > ratios > PB
0.18039209410324122
Quarters > 3 > ratios > ROE
0.6638742028999228
Quarters > 3 > ratios > ROA
0.3580265719455694
Quarters > 3 > ratios > FCF
79669000
Quarters > 3 > ratios > Piotroski FScore
4
Quarters > 3 > ratios > fcf Percent
0.15857257020362708
Quarters > 3 > health Score
61
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
1986651000
Annuals > 0 > income Statement > cost Of Revenue
1299252000
Annuals > 0 > income Statement > gross Profit
687399000
Annuals > 0 > income Statement > operating Expenses
417810000
Annuals > 0 > income Statement > operating Income
269589000
Annuals > 0 > income Statement > interest Expense
53892000
Annuals > 0 > income Statement > pretax Income
295705000
Annuals > 0 > income Statement > net Income
167294000
Annuals > 0 > income Statement > eps
0.07811030710170952
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
2141766000
Annuals > 0 > income Statement > income Tax Expense
73718000
Annuals > 0 > income Statement > EBITDA
563458000
Annuals > 0 > income Statement > operating Margin
13.570023119309834
Annuals > 0 > income Statement > total Other Income Expense Net
26116000
Annuals > 0 > income Statement > currency_symbol
CNY
Annuals > 0 > balance Sheet > cash
941581000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
436986000
Annuals > 0 > balance Sheet > inventories
272700000
Annuals > 0 > balance Sheet > total Current Assets
1876598000
Annuals > 0 > balance Sheet > property Plant Equipment
1606609000
Annuals > 0 > balance Sheet > total Assets
7050594000
Annuals > 0 > balance Sheet > payables
309355000
Annuals > 0 > balance Sheet > short Term Debt
552484000
Annuals > 0 > balance Sheet > long Term Debt
705921000
Annuals > 0 > balance Sheet > total Liabilities
3234373000
Annuals > 0 > balance Sheet > equity
3802377000
Annuals > 0 > balance Sheet > currency_symbol
CNY
Annuals > 0 > cash Flow > net Income
295705000
Annuals > 0 > cash Flow > depreciation
213861000
Annuals > 0 > cash Flow > change In Working Capital
-32943000
Annuals > 0 > cash Flow > cash From Operations
373990000
Annuals > 0 > cash Flow > capital Expenditures
191671000
Annuals > 0 > cash Flow > cash From Investing
185899000
Annuals > 0 > cash Flow > cash From Financing
-657764000
Annuals > 0 > cash Flow > net Change In Cash
-94612000
Annuals > 0 > cash Flow > currency_symbol
CNY
Annuals > 0 > ratios > PE
0.07811030710170952
Annuals > 0 > ratios > PB
0.10747197155884332
Annuals > 0 > ratios > ROE
4.399721542603482
Annuals > 0 > ratios > ROA
2.372764620966687
Annuals > 0 > ratios > FCF
182319000
Annuals > 0 > ratios > Piotroski FScore
4
Annuals > 0 > ratios > fcf Percent
0.09177203243045709
Annuals > 0 > health Score
59
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
2155578000
Annuals > 1 > income Statement > cost Of Revenue
1417146000
Annuals > 1 > income Statement > gross Profit
738432000
Annuals > 1 > income Statement > operating Expenses
545749000
Annuals > 1 > income Statement > operating Income
192683000
Annuals > 1 > income Statement > interest Expense
176582000
Annuals > 1 > income Statement > pretax Income
-55953000
Annuals > 1 > income Statement > net Income
-116113000
Annuals > 1 > income Statement > eps
-0.057235767708937686
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
2028679000
Annuals > 1 > income Statement > income Tax Expense
43837000
Annuals > 1 > income Statement > EBITDA
391012000
Annuals > 1 > income Statement > operating Margin
8.938808987658994
Annuals > 1 > income Statement > total Other Income Expense Net
-248636000
Annuals > 1 > income Statement > currency_symbol
CNY
Annuals > 1 > balance Sheet > cash
1036322000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
407405000
Annuals > 1 > balance Sheet > inventories
259707000
Annuals > 1 > balance Sheet > total Current Assets
2030918000
Annuals > 1 > balance Sheet > property Plant Equipment
1654531000
Annuals > 1 > balance Sheet > total Assets
7449912000
Annuals > 1 > balance Sheet > payables
245756000
Annuals > 1 > balance Sheet > short Term Debt
952441000
Annuals > 1 > balance Sheet > long Term Debt
922012000
Annuals > 1 > balance Sheet > total Liabilities
3762000000
Annuals > 1 > balance Sheet > equity
3687912000
Annuals > 1 > balance Sheet > currency_symbol
CNY
Annuals > 1 > cash Flow > net Income
-55953000
Annuals > 1 > cash Flow > depreciation
211216000
Annuals > 1 > cash Flow > change In Working Capital
31415000
Annuals > 1 > cash Flow > cash From Operations
383405000
Annuals > 1 > cash Flow > capital Expenditures
187836000
Annuals > 1 > cash Flow > cash From Investing
439174000
Annuals > 1 > cash Flow > cash From Financing
-429502000
Annuals > 1 > cash Flow > net Change In Cash
357753000
Annuals > 1 > cash Flow > currency_symbol
CNY
Annuals > 1 > ratios > PE
-0.057235767708937686
Annuals > 1 > ratios > PB
0.1049569385603561
Annuals > 1 > ratios > ROE
-3.1484753432294483
Annuals > 1 > ratios > ROA
-1.5585821684873593
Annuals > 1 > ratios > FCF
195569000
Annuals > 1 > ratios > Piotroski FScore
2
Annuals > 1 > ratios > fcf Percent
0.09072694191534707
Annuals > 1 > health Score
32
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
2379631000
Annuals > 2 > income Statement > cost Of Revenue
1563952000
Annuals > 2 > income Statement > gross Profit
815679000
Annuals > 2 > income Statement > operating Expenses
546330000
Annuals > 2 > income Statement > operating Income
269349000
Annuals > 2 > income Statement > interest Expense
184674000
Annuals > 2 > income Statement > pretax Income
-459165000
Annuals > 2 > income Statement > net Income
-528475000
Annuals > 2 > income Statement > eps
-0.2759030967867907
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
1915437000
Annuals > 2 > income Statement > income Tax Expense
45055000
Annuals > 2 > income Statement > EBITDA
436354000
Annuals > 2 > income Statement > operating Margin
11.31893978520199
Annuals > 2 > income Statement > total Other Income Expense Net
-728514000
Annuals > 2 > income Statement > currency_symbol
CNY
Annuals > 2 > balance Sheet > cash
678569000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
445969000
Annuals > 2 > balance Sheet > inventories
326031000
Annuals > 2 > balance Sheet > total Current Assets
1938807000
Annuals > 2 > balance Sheet > property Plant Equipment
1937380000
Annuals > 2 > balance Sheet > total Assets
7920855000
Annuals > 2 > balance Sheet > payables
326130000
Annuals > 2 > balance Sheet > short Term Debt
1916180000
Annuals > 2 > balance Sheet > long Term Debt
880959000
Annuals > 2 > balance Sheet > total Liabilities
4316141000
Annuals > 2 > balance Sheet > equity
3604714000
Annuals > 2 > balance Sheet > currency_symbol
CNY
Annuals > 2 > cash Flow > net Income
-528475000
Annuals > 2 > cash Flow > depreciation
185454000
Annuals > 2 > cash Flow > change In Working Capital
-118752000
Annuals > 2 > cash Flow > cash From Operations
386051000
Annuals > 2 > cash Flow > capital Expenditures
249328000
Annuals > 2 > cash Flow > cash From Investing
-372804000
Annuals > 2 > cash Flow > cash From Financing
-143196000
Annuals > 2 > cash Flow > net Change In Cash
-122378000
Annuals > 2 > cash Flow > currency_symbol
CNY
Annuals > 2 > ratios > PE
-0.2759030967867907
Annuals > 2 > ratios > PB
0.10138540244801668
Annuals > 2 > ratios > ROE
-14.66066378636419
Annuals > 2 > ratios > ROA
-6.671943874745844
Annuals > 2 > ratios > FCF
136723000
Annuals > 2 > ratios > Piotroski FScore
2
Annuals > 2 > ratios > fcf Percent
0.057455546679296074
Annuals > 2 > health Score
28
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
2104083000
Annuals > 3 > income Statement > cost Of Revenue
1453102000
Annuals > 3 > income Statement > gross Profit
650981000
Annuals > 3 > income Statement > operating Expenses
414080000
Annuals > 3 > income Statement > operating Income
236901000
Annuals > 3 > income Statement > interest Expense
183108000
Annuals > 3 > income Statement > pretax Income
347701000
Annuals > 3 > income Statement > net Income
287546000
Annuals > 3 > income Statement > eps
0.14590326055574415
Annuals > 3 > income Statement > dividends Per Share
16270000
Annuals > 3 > income Statement > shares Outstanding
1970799000
Annuals > 3 > income Statement > income Tax Expense
47141000
Annuals > 3 > income Statement > EBITDA
369939000
Annuals > 3 > income Statement > operating Margin
11.259109075069757
Annuals > 3 > income Statement > total Other Income Expense Net
110800000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
800947000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
429703000
Annuals > 3 > balance Sheet > inventories
231721000
Annuals > 3 > balance Sheet > total Current Assets
1983785000
Annuals > 3 > balance Sheet > property Plant Equipment
1723901000
Annuals > 3 > balance Sheet > total Assets
8044758000
Annuals > 3 > balance Sheet > payables
281053000
Annuals > 3 > balance Sheet > short Term Debt
238744000
Annuals > 3 > balance Sheet > long Term Debt
2388179000
Annuals > 3 > balance Sheet > total Liabilities
4131402000
Annuals > 3 > balance Sheet > equity
3913356000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
347701000
Annuals > 3 > cash Flow > depreciation
153154000
Annuals > 3 > cash Flow > change In Working Capital
-261518000
Annuals > 3 > cash Flow > cash From Operations
77830000
Annuals > 3 > cash Flow > capital Expenditures
566324000
Annuals > 3 > cash Flow > cash From Investing
-868835000
Annuals > 3 > cash Flow > cash From Financing
-653159000
Annuals > 3 > cash Flow > net Change In Cash
-1507505000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
0.14590326055574415
Annuals > 3 > ratios > PB
0.09608848497300015
Annuals > 3 > ratios > ROE
7.347810932611293
Annuals > 3 > ratios > ROA
3.5743275310456823
Annuals > 3 > ratios > FCF
-488494000
Annuals > 3 > ratios > Piotroski FScore
4
Annuals > 3 > ratios > fcf Percent
-0.2321647957803946
Annuals > 3 > health Score
50
Valuation > metrics > PE
29.5
Valuation > metrics > PB
0.12297624965513201
Valuation > final Score
64.6
Valuation > verdict
34.9% Undervalued
Profitability > metrics > ROE
3.1289865325521977
Profitability > metrics > ROA
6.975843839145248
Profitability > metrics > Net Margin
0.14642241493303074
Profitability > final Score
49
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.7643345627844679
Risk > metrics > Interest Coverage
12.746395156851953
Risk > final Score
88
Risk > verdict
Low
Liquidity > metrics > Current Ratio
2.2246249498340545
Liquidity > metrics > Quick Ratio
1.820654992069003
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
90
Prev Valuations > 1
90
Prev Valuations > 2
90
Prev Profitabilities > 0
36
Prev Profitabilities > 1
18
Prev Profitabilities > 2
13
Prev Risks > 0
59
Prev Risks > 1
87
Prev Risks > 2
52
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:46:24.034Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-26
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2021-03-31
Earnings History > 1 > report Date
2021-06-30
Earnings History > 1 > date
2021-03-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
CNY
Earnings History > 1 > eps Actual
0.0031
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
0.0031
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2020-12-31
Earnings History > 2 > report Date
2021-03-30
Earnings History > 2 > date
2020-12-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
CNY
Earnings History > 2 > eps Actual
0.0031
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
0.0031
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2020-09-30
Earnings History > 3 > report Date
2020-12-31
Earnings History > 3 > date
2020-09-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
CNY
Earnings History > 3 > eps Actual
0.0063
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
0.0063
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2020-06-30
Earnings History > 4 > report Date
2020-08-31
Earnings History > 4 > date
2020-06-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
CNY
Earnings History > 4 > eps Actual
0.006
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
0.006
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2020-03-31
Earnings History > 5 > report Date
2020-06-30
Earnings History > 5 > date
2020-03-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
CNY
Earnings History > 5 > eps Actual
-0.0269
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
-0.0269
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2019-12-31
Earnings History > 6 > report Date
2020-03-30
Earnings History > 6 > date
2019-12-31
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
CNY
Earnings History > 6 > eps Actual
-0.0268
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
-0.0268
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2019-09-30
Earnings History > 7 > report Date
2019-12-31
Earnings History > 7 > date
2019-09-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
CNY
Earnings History > 7 > eps Actual
0.0099
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
0.0099
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2019-06-30
Earnings History > 8 > report Date
2019-08-27
Earnings History > 8 > date
2019-06-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
CNY
Earnings History > 8 > eps Actual
0.0097
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
0.0097
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2019-03-31
Earnings History > 9 > report Date
2019-04-24
Earnings History > 9 > date
2019-03-31
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
CNY
Earnings History > 9 > eps Actual
0.0022
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
0.0022
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2018-12-31
Earnings History > 10 > report Date
2019-03-31
Earnings History > 10 > date
2018-12-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
CNY
Earnings History > 10 > eps Actual
0.0022
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
0.0022
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2018-09-30
Earnings History > 11 > report Date
2018-12-31
Earnings History > 11 > date
2018-09-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
CNY
Earnings History > 11 > eps Actual
0.0027
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
0.0027
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2018-06-30
Earnings History > 12 > report Date
2018-09-30
Earnings History > 12 > date
2018-06-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
CNY
Earnings History > 12 > eps Actual
0.0027
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
0.0027
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2018-03-31
Earnings History > 13 > report Date
2018-06-30
Earnings History > 13 > date
2018-03-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
CNY
Earnings History > 13 > eps Actual
0.003
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
0.003
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2017-12-31
Earnings History > 14 > report Date
2018-03-31
Earnings History > 14 > date
2017-12-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
CNY
Earnings History > 14 > eps Actual
0.0032
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
0.0032
Earnings History > 14 > surprise Percent
-
Viva Biotech Holdings, an investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide. The company provides discovery biology services, including protein expression and purification, structural biology, hit discovery, bioassay, biomolecular interaction, and pharmacology and DMPK; chemistry services, such as medicinal and synthetic chemistry, analytical chemistry, purification preparation, and computer-aided drug design services, as well as offers chemical technology platforms; and antibody/biologics research and development services comprising recombinant protein expression platform, antibody discovery and affinity maturation, assay platform, antibody production and identification platform, and antigen-antibody structural resolution platform solutions. It also offers PROTAC/molecular glue services, including protein preparation and ternary complex structure determination, screening for molecule glues and novel E3 ligase ligands, PROTAC ternary complex kinetics, PROTAC degradation assays and ternary complex assays, PROTAC molecule design and synthesis, ADME & PK/PD studies of PROTAC molecules, and computer aided PROTAC design solutions; and XDC platforms, such as XDC conjugation and quality study, XDC chemistry research and development, and XDC functional studies. In addition, the company offers contract development and manufacturing services comprising integrated services for small molecule active pharmaceutical ingredients, formulation development and production services, and pharmaceutical analysis services, as well as CMC filing, global filing registration support, and other services. Further, it provides research services. The company was incorporated in 2008 and is headquartered in Shanghai, China.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-06-30)
Health Score
Price to Earnings Ratio (P/E)
-
Medium
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Viva Biotech Holdings
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
2021-03-31
EPS Actual
0.0031
EPS Estimate
0
EPS Difference
0.0031
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.